Stay updated on Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial
Sign up to get notified when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.

Latest updates to the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check33 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check76 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new collaborators and a revision update, while extensive details about the study's purpose, methodology, and participant criteria have been removed.SummaryDifference33%
Stay in the know with updates to Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.